Guardian Pharmacy Services, Inc.

GRDN
Exchange
NYSE
Industry
Retail-Drug Stores and Proprietary Stores
SEC CIK
0001802255

Price chart

Open-market purchases and sales by GRDN insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Mar 24, 2026Mar 20, 2026Morris David KSee RemarksSSaleClass A Common Stock−187.86K$29.68−$5.58M254.47K−42.5%SEC
Mar 24, 2026Mar 20, 2026Pharmacy Investors, LLCOther: Member of 10% owner groupSSaleClass A Common Stock−827.64K$29.68−$24.56M1.04M−44.4%SEC
Mar 24, 2026Mar 20, 2026Burke FredSee RemarksSSaleClass A Common Stock−671.43K$29.68−$19.93M840.41K−44.4%SEC
Mar 24, 2026Mar 20, 2026Salentine Thomas J JrDirector, 10% OwnerSSaleClass A Common Stock−3.57M$29.68−$105.98M4.47M−44.4%SEC
Mar 24, 2026Mar 20, 2026Bindley Capital Partners I, LLC10% OwnerSSaleClass A Common Stock−3.57M$29.68−$105.98M4.47M−44.4%SEC

The largest institutional positions in GRDN at the end of Q2 2026.

Institutions holding GRDN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC3,241,612$135.73M0.01%+882,255+37.4%Added
WELLINGTON MANAGEMENT GROUP LLP1,729,032$72.39M0.01%−36,087−2.0%Reduced
BlackRock, Inc.1,575,989$65.99M0.00%−180,385−10.3%Reduced
VANGUARD CAPITAL MANAGEMENT LLC1,379,750$57.77M0.00%+154,207+12.6%Added
Woodline Partners LP1,306,340$54.7M0.17%+220.0%Added